Nabriva.com


Keyword Suggestion

Nabriva therapeutics
Nabriva
Nabriva stock
Nabriva therapeutics plc
Nabriva therapeutics ag
Nabriva therapeutics ireland dac
Nabriva therapeutics sede
Nabriva therapeutics news
Nabriva stock forecast cnn
Nabriva therapeutics azioni
Nabriva therapeutics farmaci
Nabriva therapeutics contatti
Nabriva therapeutics opinioni
Nabriva therapeutics stock
Nabriva stock forecast 2021



Domain Informations

Nabriva.com lookup results from whois.corporatedomains.com server:
  • Domain created: 2006-01-23T21:20:36Z
  • Domain updated: 2024-01-19T06:07:19Z
  • Domain expires: 2025-01-23T21:20:36Z 0 Years, 133 Days left
  • Website age: 18 Years, 231 Days
  • Registrar Domain ID: 324987402_DOMAIN_COM-VRSN
  • Registrar Url: http://cscdbs.com
  • Registrar WHOIS Server: whois.corporatedomains.com
  • Registrar Abuse Contact Email: [email protected]
  • Registrar Abuse Contact Phone: 8887802723
  • Name server:
    • DNS1.CSCDNS.NET
    • DNS2.CSCDNS.NET

Network
  • inetnum : 52.145.0.0 - 52.191.255.255
  • name : MSFT
  • handle : NET-52-145-0-0-1
  • status : Direct Allocation
  • created : 1998-07-10
  • changed : 2024-03-18
  • desc : To report suspected security issues specific to traffic emanating from Microsoft online services, including the distribution of malicious content or other illicit or illegal material through a Microsoft online service, please submit reports to:,* https://cert.microsoft.com.,For SPAM and other abuse issues, such as Microsoft Accounts, please contact:,* [email protected].,To report security vulnerabilities in Microsoft products and services, please contact:,* [email protected].,For legal and law enforcement-related requests, please contact:,* [email protected],For routing, peering or DNS issues, please,contact:,* [email protected]
Owner
  • organization : Microsoft Corporation
  • handle : MSFT
  • address : Array,Redmond,WA,98052,US
Technical support
  • handle : IPHOS5-ARIN
  • name : IPHostmaster, IPHostmaster
  • phone : +1-425-538-6637
  • email : [email protected]
Abuse
  • handle : MAC74-ARIN
  • name : Microsoft Abuse Contact
  • phone : +1-425-882-8080
  • email : [email protected]
Domain Provider Number Of Domains
godaddy.com 286730
namecheap.com 101387
networksolutions.com 69118
tucows.com 52617
publicdomainregistry.com 39120
whois.godaddy.com 32793
enomdomains.com 23825
namesilo.com 21429
domains.google.com 21384
cloudflare.com 20573
gmo.jp 18110
name.com 17601
fastdomain.com 14708
register.com 13495
net.cn 12481
ionos.com 12416
ovh.com 12416
gandi.net 12305
registrar.amazon.com 12111


Host Informations

  • IP address: 52.176.165.69
  • Location: Des Moines United States
  • Latitude: 41.6006
  • Longitude: -93.6112
  • Timezone: America/Chicago

Check all domain's dns records


See Web Sites Hosted on 52.176.165.69

Fetching Web Sites Hosted


Site Inspections


Port Scanner (IP: 52.176.165.69)

 › Ftp: 21
 › Ssh: 22
 › Telnet: 23
 › Smtp: 25
 › Dns: 53
 › Http: 80
 › Pop3: 110
 › Portmapper, rpcbind: 111
 › Microsoft RPC services: 135
 › Netbios: 139
 › Imap: 143
 › Ldap: 389
 › Https: 443
 › SMB directly over IP: 445
 › Msa-outlook: 587
 › IIS, NFS, or listener RFS remote_file_sharing: 1025
 › Lotus notes: 1352
 › Sql server: 1433
 › Point-to-point tunnelling protocol: 1723
 › My sql: 3306
 › Remote desktop: 3389
 › Session Initiation Protocol (SIP): 5060
 › Virtual Network Computer display: 5900
 › X Window server: 6001
 › Webcache: 8080


Spam Check (IP: 52.176.165.69)

 › Dnsbl-1.uceprotect.net:
 › Dnsbl-2.uceprotect.net:
 › Dnsbl-3.uceprotect.net:
 › Dnsbl.dronebl.org:
 › Dnsbl.sorbs.net:
 › Spam.dnsbl.sorbs.net:
 › Bl.spamcop.net:
 › Recent.dnsbl.sorbs.net:
 › All.spamrats.com:
 › B.barracudacentral.org:
 › Bl.blocklist.de:
 › Bl.emailbasura.org:
 › Bl.mailspike.org:
 › Bl.spamcop.net:
 › Cblplus.anti-spam.org.cn:
 › Dnsbl.anticaptcha.net:
 › Ip.v4bl.org:
 › Fnrbl.fast.net:
 › Dnsrbl.swinog.ch:
 › Mail-abuse.blacklist.jippg.org:
 › Singlebl.spamgrouper.com:
 › Spam.abuse.ch:
 › Spamsources.fabel.dk:
 › Virbl.dnsbl.bit.nl:
 › Cbl.abuseat.org:
 › Dnsbl.justspam.org:
 › Zen.spamhaus.org:


Email address with nabriva.com


Recent Searched Sites

Uk.appewa.com (15 seconds ago) / US

Sancogrup.ro (8 seconds ago) / RO

Capeindustrialflooring.co.za (3 seconds ago) / ZA

Dewporn.com (51 seconds ago) / US

Link22.world (19 seconds ago) / IR

Crystalherbs.com (43 seconds ago) / US

Elia.com.mt (25 seconds ago) / US

Gtamerica.us (15 seconds ago) / GB

Emoji.supply (1 mins ago) / US

Kolmelhior.ru (8 seconds ago) / RU

Nabriva.com (0 seconds ago) / US

Rovelver.com (7 seconds ago) / US

Media.clubrural.com (57 seconds ago) / UA

Carolineamiguet.com (0 seconds ago) / US

Jmana.net (6 seconds ago) / US

Dancingyaksf.com (4 seconds ago) / US

Flynumber.com (4 seconds ago) / US

Ayushcare.in (4 seconds ago) / CA

Hvizdateam.com (8 seconds ago) / US

Headlinespaperd.blogspot.com (14 seconds ago) / US

Websites Listing

We found Websites Listing below when search with nabriva.com on Search Engine

Nabriva Announces Availability of XENLETA® (lefamulin) in ...

2021-11-11  · Email Alerts; Nabriva Announces Availability of XENLETA® (lefamulin) in a 10-Count Oral Pack. Nabriva Announces Availability of XENLETA® (lefamulin) in a 10-Count Oral Pack . November 11, 2021 at 7:01 AM EST. 10-count oral pack – or ‘X’ pack allows for improved access and the opportunity to further expand retail availability. DUBLIN, Ireland and FORT …

Investors.nabriva.com

Nabriva Therapeutics | Company Email | Telephone | Contact ...

Contact details (email, telephone numbers etc.) for Nabriva Therapeutics

Pharmacompass.com

nabriva

Reset password. Enter your username or email address and we'll email you instructions on how to reset your password

Nabriva.talentlms.com

Investor Relations | Nabriva Therapeutics

2018-01-10  · Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of novel antibiotics to treat serious infections. Nabriva Therapeutics has two products: Xenleta® (lefamulin), approved by the FDA in 2019 for both Oral and IV use, and CONTEPO (fosfomycin) for injection. The approval of CONTEPO has been impacted by FDA’s …

Investors.nabriva.com

Nabriva Corporate > About Nabriva > Our Products

© Nabriva Therapeutics plc, Ireland Registration No. 599588, 25-28 North Wall Quay, Dublin 1, Ireland

Nabriva.com

Nabriva Therapeutics Reports Inducement Grant Under Nasdaq ...

2 days ago  · Nabriva Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Mar 01, 2022 - read this article along with other careers information, tips and advice on BioSpace Nabriva Therapeutics plc announced that it has granted a non-statutory stock option to purchase an aggregate of 12,000 ordinary shares of Nabriva Therapeutics as an …

Biospace.com

StockNews.com Initiates Coverage on Nabriva Therapeutics ...

2022-03-03  · Nabriva Therapeutics has a fifty-two week low of $0.40 and a fifty-two week high of $2.33. In other Nabriva Therapeutics news, CEO Theodore R. Schroeder bought 100,000 shares of the firm's stock in a transaction that occurred on Tuesday, December 28th. The stock was bought at an average price of $0.57 per share, for a total transaction of ...

Marketbeat.com

Nabriva Therapeutics plc (NBRV) Stock Price, News, Quote ...

Nabriva Therapeutics Adjourns Extraordinary General Meeting of Shareholders on January 18, 2022. — Meeting to Reconvene on March 24, 2022 — DUBLIN, Ireland and FORT WASHINGTON, Pa., Jan. 18 ...

Finance.yahoo.com

Nabriva Therape Ads (NBRV-Q) Quote - Press Release - The ...

2001-07-22  · Nabriva Therapeutics to Report First Quarter 2021 Financial Results and Recent Corporate Highlights on May 6, 2021. GlobeNewswire - Fri Apr 30, 8:46AM CDT. Nabriva Therapeutics plc ( NASDAQ:NBRV ...

Theglobeandmail.com

Additional Proxy Soliciting Materials (definitive) (defa14a)

2022-01-14  · Nabriva Therapeutics Adjourns . Extraordinary General Meeting of Shareholders — Meeting to Reconvene on January 18, 2022 — DUBLIN, Ireland and FORT WASHINGTON, Pa., January 14, 2022 — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat …

Ih.advfn.com

Nabriva Therape Ads (NBRV-Q) Quote - Press Release - The ...

Nabriva Therapeutics Announces $25.4 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules. GlobeNewswire - Mon Mar 1, 7:00AM CST. Nabriva Therapeutics plc ( NASDAQ:NBRV ), a ...

Theglobeandmail.com

Nabriva Therape Ads (NBRV-Q) Quote - Press Release - The ...

Nabriva Therapeutics anticipates that subsequent events and developments will cause its views to change. However, while Nabriva Therapeutics may elect to update these forward-looking statements at ...

Theglobeandmail.com

NBRV Nabriva Therapeutics — Stock Price and Discussion ...

2022-02-19  · NBRV Nabriva Therapeutics — Stock Price and Discussion | Stocktwits. Nabriva Therapeutics NASDAQ Updated Feb 19, 2022 12:20 AM. NBRV 0.51 0.02 (3.21%) Post-Market 0.01 (1.98%) 17,140. Key Data. 52wk Low 0.41.

Stocktwits.com

Theodore R. Schroeder Net Worth, Biography & Insider ...

2021-12-28  · The corporate mailing address for Mr. Schroeder and other Nabriva Therapeutics executives is 25-28 NORTH WALL QUAY IFSC, DUBLIN L2, 19406. Nabriva Therapeutics can also be reached via phone at (531) 649-2000 and via email at [email protected]

Insidertrades.com

Additional Proxy Soliciting Materials (definitive) (defa14a)

2022-02-22  · Nabriva Therapeutics plc, an Irish public limited company (the “Company”) originally convened an extraordinary general meeting of its shareholders for December 22, 2021. However, this meeting was adjourned to March 24, 2022 to allow the Company to solicit from its shareholders the additional proxies necessary to obtain approval of the proposal described in …

Ih.advfn.com

PETE WOLF, general counsel, nabriva therapeutics

Verify the professional email of PETE WOLF, general counsel, nabriva therapeutics. Email-verifier.io : the best email verifier in the world. Email-verifier.io. Back to homepage Email-Verifier.io is the BEST email verifier in the world. Test us for free! First Name: Pete ...

Directory.email-verifier.io

ANDREW RANALLI, Corporate audit, nabriva therapeutics

Professional Email of Andrew Ranalli: [email protected] . Test the validity of this email address. Professional Email of Andrew Ranalli: [email protected] . Test the validity of this email address. Professional Email of Andrew Ranalli: [email protected] . Test the validity of this email address ...

Directory.email-verifier.io

Nabriva Therapeutics Announces $25.4 Million Registered ...

2021-03-01  · About Nabriva Therapeutics plc Nabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections ...

Finance.yahoo.com

Nabriva Therape Ads (NBRV-Q) Press Releases - The Globe ...

2022-01-14  · Latest Press Releases for Nabriva Therape Ads (NBRV-Q). Skip to main content. Canada’s most-awarded newsroom for a reason . Enjoy unlimited digital access. $1.99. per …

Theglobeandmail.com

XENLETA® (lefamulin) - WEP Clinical

Manufacturer: Nabriva Therapeutics U.S. INC. The XENLETA Named Patient Program is designed to ensure that physicians can request IV or oral XENLETA on behalf of patients who meet the necessary eligibility criteria and who live in certain countries where it is not yet available. If you would like to order XENLETA, please contact us using the email below: …

Wepclinical.com


Domains Expiration Date Updated

Site Provider Expiration Date
amorganinteriors.com srsplus.com -1 Years, -344 Days
crossroads4hope.org whois.godaddy.com -1 Years, -314 Days
crystaldigest.com namecheap.com 88 Days
firagran.com dondominio.com -1 Years, -208 Days
kwk.us domains.google 343 Days
kreweofjustinian.com wildwestdomains.com -2 Years, -56 Days
preventis.com ionos.com -2 Years, -38 Days
mag7raceseries.com domain.com 43 Days
fvf-bff.org openprovider.com -2 Years, -180 Days
evlear.com one.com -2 Years, -120 Days

    Browser All

    .com4.3M domains   

    .org1M domains   

    .edu40.9K domains   

    .net616.8K domains   

    .gov15.9K domains   

    .us30.9K domains   

    .ca45.1K domains   

    .de560K domains   

    .uk466.1K domains   

    .it35K domains   

    .au46.7K domains   

    .co34.2K domains   

    .biz13.9K domains   

    .info36.4K domains   

    .fr37.6K domains   

    .eu24.7K domains   

    .ru195.7K domains   

    .ph5.6K domains   

    .in54.2K domains   

    .vn18.9K domains   

    .cn40.4K domains   

    .ro19.5K domains   

    .ch11.7K domains   

    .at10.3K domains   

    Browser All